Last reviewed · How we verify
NCT03455374: DIAMOND-PAD
Diamondback in Peripheral Vascular Disease
NA trial testing Treatment with CSI atherectomy device in Peripheral Vascular Diseases in 10 participants. Terminated before completion.
13 May 2019
Quick facts
| Lead sponsor | Arkansas Heart Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 8 August 2017 |
| Primary completion | 13 May 2019 |
| Estimated completion | 13 May 2019 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Treatment with CSI atherectomy device
Conditions studied
- Peripheral Vascular Diseases — all drugs for Peripheral Vascular Diseases →
- Critical Limb Ischemia — all drugs for Critical Limb Ischemia →
Sponsor
Arkansas Heart Hospital
Who can join
18 and older, any sex, with Peripheral Vascular Diseases or Critical Limb Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, nonrandomized, single-arm study using CSI Orbital Atherectomy System in patients with PAD (total occlusions or significant stenosis). Patients will be enrolled if they have claudication and/or critical limb ischemia, and identifiable PAD disease with moderate to severe calcification on Computer Tomography Angiogram (PCA) or peripheral angiogram requiring percutaneous peripheral intervention (PPI).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03455374
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Peripheral Vascular Diseases
Currently open trials in the same condition.
- NCT06094491 — Virtual Diabetes Group Visits Across Health Systems · Phase 2 · active not recruiting
- NCT06032065 — SMART Exercise for PAD · Phase 3 · recruiting
- NCT06300450 — Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not · NA · recruiting
- NCT04916340 — Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3 · NA · recruiting
- NCT04016649 — The Mechanical Characterisation of Human Saphenous and Popliteal Vein · recruiting
Other Arkansas Heart Hospital trials
Trials by the same sponsor.
- NCT05708313 — Effects of 9-18 Weeks of Intensive Cardiac Rehabilitation After a Major Cardiovascular Event in Patients With CVD · NA · completed
- NCT02756884 — Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD · EARLY_PHASE1 · completed
- NCT02161744 — Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPD · Phase 1 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03455374 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arkansas Heart Hospital
- Last refreshed: 27 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03455374.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing